Adan Medical Innovation, SL

First eHealth integrated digital solution consisting of a medical device and mobile APP for epinephrine autoinjectors (2.000M€ market and growing), solving all the issues reported by patients in anaphylaxis (severe allergic reaction) management: drug monitoring, distance from autoinjector (prevents forgetting it) and automated emergency protocol with video-instructions and alert to contacts & services with GPS location.

In addition, we’ve developed a Smart Box for public spaces (similar than AED: 10.000M€ market), “anticipating” the legal trends of epinephrine in schools, restaurants…

We’re in a 440.000€ round with Capital Cell (preindustrialization and regulatory approach) and are looking for a series A of 3.5M€ to launch our products.



Deja un comentario

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *